Literature DB >> 8242623

Therapeutic tumor-specific cell cycle block induced by methionine starvation in vivo.

H Guo1, V K Lishko, H Herrera, A Groce, T Kubota, R M Hoffman.   

Abstract

The ability to induce a specific cell cycle block selectively in the tumor could have many uses in chemotherapy. In the present study we have achieved this goal of inducing a tumor-specific cell cycle block in vivo by depriving Yoshida sarcoma-bearing nude mice of dietary methionine. Further, we demonstrate that methionine depletion also causes the tumor to eventually regress. The antitumor effect of methionine depletion resulted in the extended survival of the tumor-bearing mice. The mice on the methionine-deprived diets maintained their body weight for the time period studied, indicating that tumor regression was not a function of body weight loss. The data reported here support future experiments utilizing methionine depletion as a target for tumor-selective cell cycle-dependent therapy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8242623

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  47 in total

1.  Methionine Deprivation Induces a Targetable Vulnerability in Triple-Negative Breast Cancer Cells by Enhancing TRAIL Receptor-2 Expression.

Authors:  Elena Strekalova; Dmitry Malin; David M Good; Vincent L Cryns
Journal:  Clin Cancer Res       Date:  2015-02-27       Impact factor: 12.531

2.  Targeting altered cancer methionine metabolism with recombinant methioninase (rMETase) overcomes partial gemcitabine-resistance and regresses a patient-derived orthotopic xenograft (PDOX) nude mouse model of pancreatic cancer.

Authors:  Kei Kawaguchi; Kentaro Miyake; Qinghong Han; Shukuan Li; Yuying Tan; Kentaro Igarashi; Thinzar M Lwin; Takashi Higuchi; Tasuku Kiyuna; Masuyo Miyake; Hiromichi Oshiro; Michael Bouvet; Michiaki Unno; Robert M Hoffman
Journal:  Cell Cycle       Date:  2018-05-21       Impact factor: 4.534

3.  Targeting methionine with oral recombinant methioninase (o-rMETase) arrests a patient-derived orthotopic xenograft (PDOX) model of BRAF-V600E mutant melanoma: implications for chronic clinical cancer therapy and prevention.

Authors:  Kei Kawaguchi; Qinghong Han; Shukuan Li; Yuying Tan; Kentaro Igarashi; Tasuku Kiyuna; Kentaro Miyake; Masuyo Miyake; Bartosz Chmielowski; Scott D Nelson; Tara A Russell; Sarah M Dry; Yunfeng Li; Arun S Singh; Mark A Eckardt; Michiaki Unno; Fritz C Eilber; Robert M Hoffman
Journal:  Cell Cycle       Date:  2018-03-19       Impact factor: 4.534

4.  S-adenosylmethionine biosynthesis is a targetable metabolic vulnerability of cancer stem cells.

Authors:  Elena Strekalova; Dmitry Malin; Erin M M Weisenhorn; Jason D Russell; Dominik Hoelper; Aayushi Jain; Joshua J Coon; Peter W Lewis; Vincent L Cryns
Journal:  Breast Cancer Res Treat       Date:  2019-02-02       Impact factor: 4.872

5.  Akt phosphorylation and regulation of transketolase is a nodal point for amino acid control of purine synthesis.

Authors:  Arindam Saha; Stephen Connelly; Jingjing Jiang; Shunhui Zhuang; Deron T Amador; Tony Phan; Renate B Pilz; Gerry R Boss
Journal:  Mol Cell       Date:  2014-06-26       Impact factor: 17.970

6.  Oncogenic PI3K promotes methionine dependency in breast cancer cells through the cystine-glutamate antiporter xCT.

Authors:  Evan C Lien; Laura Ghisolfi; Renee C Geck; John M Asara; Alex Toker
Journal:  Sci Signal       Date:  2017-12-19       Impact factor: 8.192

7.  Allowing awe in life.

Authors:  Daniel E Epner
Journal:  Am J Clin Exp Urol       Date:  2018-04-01

8.  Tumor-specific cell-cycle decoy by Salmonella typhimurium A1-R combined with tumor-selective cell-cycle trap by methioninase overcome tumor intrinsic chemoresistance as visualized by FUCCI imaging.

Authors:  Shuya Yano; Kiyoto Takehara; Ming Zhao; Yuying Tan; Qinghong Han; Shukuan Li; Michael Bouvet; Toshiyoshi Fujiwara; Robert M Hoffman
Journal:  Cell Cycle       Date:  2016-05-06       Impact factor: 4.534

9.  Downregulation of Cdc6 and pre-replication complexes in response to methionine stress in breast cancer cells.

Authors:  Keith Booher; Da-Wei Lin; Stacey L Borrego; Peter Kaiser
Journal:  Cell Cycle       Date:  2012-11-16       Impact factor: 4.534

10.  Methionine depletion with recombinant methioninase: in vitro and in vivo efficacy against neuroblastoma and its synergism with chemotherapeutic drugs.

Authors:  Jian Hu; Nai-Kong V Cheung
Journal:  Int J Cancer       Date:  2009-04-01       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.